Susan Hasty, Publisher
Table of Contents . . . August 30th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Biotech Business Week | Other Publications
Angina - Trial of Ranexa initiated for certain patients with chronic angina
Genetics - Company brings genetics product to North American genealogists
Immunology - VIG product submitted for FDA approval
Mergers & Acquisitions - Fisher Scientific completes merger
Pelvic Organ Prolapse - Device firm reports early physician experience with bladder repair system
Smallpox - FDA accepts BLA filing for Vaccinia Immune Globulin
Adverse Drug Effects - Agency highlights risk of adverse drug reactions arising from the use of SonoVue
Alcoholism - Brief intervention can help alcohol abusers
Allergies - President Bush signs bill that will benefit millions with food allergies
Allergy - CD28 is required in the effector phase of allergic airway inflammation
Alzheimer Disease - Drug discovery company receives award from Institute on Aging
Alzheimer Disease - Researchers find protein that may control progression of Alzheimer disease
Amyotrophic Lateral Sclerosis - CHIP promotes proteasomal degradation of familial ALS-linked mutant
Amyotrophic Lateral Sclerosis - New biomarker study to identify unique metabolic signatures for ALS
Anemia - Aranesp receives positive regulatory opinion for extended dosing in E.U.
Angiogenesis - BNO69 angiogenesis gene discovery published in scientific journal
Angioplasty - Recall of Taxus coronary stent system expanded
Antioxidants - Research confirms cranberry is one of the best sources of antioxidants
Awards - Healthcare alliance receives URAC utilization management accreditation
Blood Banking - Cord blood company initiates lawsuits to protect patent rights
Breast Cancer - Orphan drug designation granted from U.S. FDA for Efaproxyn
Breast Implants - Tissue inhibitors of MMPs increased in women with capsular contracture
Business & Finance - $1.2M NIH grant awarded for continued research on bead-based proteomic arrays
Business & Finance - Behavioral health company announces financial results, new hires
Business & Finance - Biopharmaceutical outsourcing organization reports financial results
Business & Finance - Bioscience company reports financial results, provides business update
Business & Finance - Cardiac device maker reports 9% increase in revenue
Business & Finance - Company reports $8.8M Q2 loss, provides clinical update
Business & Finance - Life sciences company reports on second quarter 2004 results
Business & Finance - LymphoStat-B maker reports losses, milestones in Q2 2004
Business & Finance - Medical oncology device company announces financial results
Business & Finance - Oral fluid diagnostics producer announces second quarter results
Business & Finance - Pharma company reports second quarter 2004 results
Business & Finance - Pharmaceutical firm reports on IPO, financial results
Business & Finance - Radiation therapy provider reports second quarter 2004 financial results
Business & Finance - Software releases credited for company's Technology Fast 50 ranking
Business & Finance - Surgical group enters agreement with Oklahoma not-for-profit health system
Business & Finance - Tender offer extended for NeighborCare
Business & Finance - Univ. of Rochester picks supply chain business partner for medical facilities
Business Update - 35,000 units of Heinz Baby Basics Hand and Face Wipes shipped
Business Update - BioScience company and Kreatech Biotechnology sign license agreement
Business Update - Biological products manufacturer extends distribution alliance with Hitachi
Business Update - Biopharmaceutical company and ARC Ventures form Phytomedicinal Greenhouses
Business Update - Bioscience company retains McDermott Will & Emery
Business Update - Biotech firm creates BioSystems division
Business Update - Cardiology systems producer named one of Washington's fastest-growing companies
Business Update - Clinical research organizations expands its geographic footprints into Asia
Business Update - Company renames laser venous system
Business Update - Financial tool provider announces two payor contracts
Business Update - Florida professional corporation offers to buy North Ridge Medical Center
Business Update - Generics producer granted rights for fluconazole, intends to file antiretroviral
Business Update - Health care cost management company adds customers in second quarter of 2004
Business Update - Insurance department monitors HealthGuard's withdrawal from market
Business Update - Integrity Healthcare named agency of record for PhosLo calcium-based binder
Business Update - Life sciences company declares dividend, partners to study proteomics biomarker
Business Update - Ophthalmic device firm to sell Complete Aquavision contact lenses
Business Update - Orthopedics supply contract signed with Premier, Inc.
Business Update - Pharma company announces stock conversion, new hires, legal settlement
Business Update - Pharma company launches campaign against sellers of illegal Viagra
Business Update - Pharma company reports status of NTP test kit, E. coli contamination product
Business Update - Pharmaceutical company licenses compound from Millennium Pharmaceuticals
Business Update - Pharmaceutical firm loses Aetna contract
Business Update - Pittsburgh incubator signs Revivicor, Inc. as new tenant
Business Update - Study finds pharma companies spend 24% of marketing budgets on thought leaders
Business Update - Study shows home healthcare products and services market rapidly expanding
Business Update - Telemedicine company says shipments jumped 51% in first half of 2004
Cancer Therapy - Biotechnology company and ViroTarg sign anticancer license agreement
Cancer Therapy - Independent laboratory and Merck & Co., Inc., sign oncology research partnership
Cancer Therapy - Pharma company announces publication of study examining Talabostat
Cancer Therapy - Positive data reported at ASCO on T-cell-guided therapy
Cardiovascular Disease - Biopharmaceutical company achieves $3M milestone in cardiovascular collaboration
Cardiovascular Disease - FDA approves Lipitor to lower risk of heart attacks
Cardiovascular Disease - JAMA publishes long-term findings of REPLACE-2 angioplasty clinical trial
Cardiovascular Disease - Pre-IND meeting held with FDA for platelet aggregation inhibitor
Cardiovascular Health - New Ester-E product now on retail shelves
Clinical Trial - Research finds pharma companies refine tactics to attract top investigators
Collaborations - Alliance to develop new screening libraries for the identification of future drugs
Collaborations - CompuCyte, university announce program to validate tumor-fighting compounds
Collaborations - Deal signed for sales of antibacterial hand spray
Collaborations - Development agreement signed for medical device bioactive coating
Collaborations - EAU signs joint venture agreement for drinking water product
Collaborations - Jubilant Biosys and visual informatics software provider partner
Collaborations - Pd EnCat distribution deal signed with Sigma-Aldrich
Collaborations - University signs deal for cancer gene therapy
Colon Cancer - Clinic's participation in colon cancer drug study provides access to new therapy
Colon Cancer - New colorectal cancer test information published
Colon Cancer - Patient enrollment complete for phase I study for colorectal cancer
Coronary Artery Bypass - First recipient of synthetic CABG reaches 1-year milestone
Coronary Artery Disease - Clinical trial to study anticoagulant for coronary artery bypass graft surgery
DNA Research - A novel three-dimensional DNA microarray platform is developed
DNA Sequencing - Finch Sequencing Center with Genotyping Data Manager component released
Deep Vein Thrombosis - Study supports use of blood thinners to reduce risk of pulmonary embolism
Diabetes Control - New book breaks ground in battle against Type 2 diabetes epidemic
Diabetes Therapy - Company posts trial data for three insulin formulations
Diabetes Therapy - New glycogen phosphorylase inhibitors characterized
Diabetes Therapy - Supply of Sucanon diabetes drug boosted in preparation for Mexico launch
Diabetic Nephropathy - Losartan improves glomerular structural changes in diabetic mice
Diagnostics - Company launches FDA-cleared high sensitivity Troponin I assay
Diagnostics - GTx collaborates to develop a diagnostic test to detect high-grade PIN
Diagnostics - Proteomics company files for patent, continues validation of NuroPro
Diet & Nutrition - Isoflavones in nursing rats' diet alter PR regulation by estrogen
Diet Trends - Research shows number of adults on low-carb diet remains stable
Digestion - Protein, peptide and non-peptide drug PEGylation for therapeutic application
Distribution Agreement - Honeywell announces distribution agreement with GlaxoSmithKline India division
Drug Delivery - Pharma company files patent on asymmetrical multiple layered tablet
Drug Delivery - Vision system launched for use with human growth hormone in Japan
Drug Development - Biopharmaceutical company announces manufacturing agreement for anemia drug
Drug Development - Clinical development specialist reports the completion of a micro dosing study
Drug Development - Commercial manufacture of synthetic heparin on track after successful scale-up
Drug Development - Drug discovery company to utilize functional cell-based assay platform
Drug Development - GlaxoSmithKline to terminate topotecan agreement
Drug Development - Orphan drug designation granted for key component in liver assist program
Drug Development - U.S. FDA approves new drug application for generic topical cortisone ointment
Drug Development - U.S. patent more broadly protects Transfluor compositions of matter technology
Drug Discovery - Animal models identified as a major hurdle in drug discovery and development
Drug Discovery - Biotechnology company announces U.S. patent covering Transfluor technology
Drug Discovery - Customized IT solution facilitates cell-based drug discovery
Drug Discovery - Pharmaceutical company enters software, custom services licensing agreement
Drug Discovery - Software company introduces computer-assisted drug discovery software
Drug Manufacturing - Audit of HIV/AIDS drug manufacturing reveals anomalies
Drug Security - Drug companies approach brand security issue head on, study shows
Embryonic Research - Embryos constructed through somatic cell nuclear transfer
End-Stage Renal Failure - Pentoxifylline improves hemoglobin in ESRD rh-Epo-resistant anemia patients
Endocrine Disorders - Methylprednisolone Sodium Succinate approved by FDA
Epstein-Barr Virus - Evolution of Epstein-Barr virus-encoded oncogene LMP1 studied
Eye Health - Medical device company profiled in report on presbyopia and glaucoma treatments
Eye Health - Pfizer commits $1.5 million to Glaucoma EyeCare Program
Fabry Disease - Phase I trial to study AT1001 for the treatment of Fabry disease
Facilities - Hospital company returns San Pablo hospital to West Contra Costa district
Fibromyalgia - Milnacipran recently featured in fibromyalgia article
Finance - Aesthetic laser company reports a 36% increase in revenue
Finance - Alferon N maker announces private placement of common stock and warrants
Finance - Antibody maker completes round of private financing
Finance - Australian biotech firm reduces annual cash expenditure by 41%
Finance - Bioanalytical measurement systems supplier announces share repurchase program
Finance - Biological implant products company reports third quarter fiscal 2004 results
Finance - Biopharmaceutical company announces financial results for second quarter
Finance - Biopharmaceutical company raises $7.5 million in private financing
Finance - Biopharmaceutical company reports increase in fourth quarter revenue
Finance - Biopharmaceutical company reports second quarter 2004 financial results
Finance - Biopharmaceutical company reports second quarter financial results
Finance - Biopharmaceutical company reports second quarter results
Finance - Biosciences firm reports 11% increase in revenues
Finance - Biotech firm announces $4M credit facility
Finance - Biotech firm reports earnings per share of $0.39
Finance - Biotech firm reports loss of $0.09 per share
Finance - Biotech firm reports net income of $0.05 per share
Finance - Biotechnology company completes $3 million private placement
Finance - Biotechnology company reports second quarter 2004 financial results
Finance - Biotechnology company reports second quarter financial results
Finance - Board of directors approves 2-for-1 stock split for pharma company
Finance - California biotech community discouraged with state budget plan
Finance - Cancer detection-focused company announces second quarter 2004 results
Finance - Cancer therapeutics company reports second quarter financial results
Finance - Cancer-focused company announces third quarter net earnings rise of 32%
Finance - Cancer-focused pharmaceutical company reports second quarter 2004 results
Finance - Capstone Investments reaffirms strong buy recommendation on device firm
Finance - Chemicals company reports first quarter fiscal 2005 results
Finance - Contract medical procedure provider announces second quarter results
Finance - Contract research organization announces second quarter results
Finance - Cubicin maker reports increased Q2 revenues
Finance - DOBI Medical International completes $5.16 million private placement
Finance - Defibrillator maker reports 20.5% increase in revenue
Finance - Dental-products company increases earnings and sales
Finance - Developer and operator of ambulatory surgery centers announces results
Finance - Developer of orthopedic biomaterials reports second quarter 2004 results
Finance - Device firm reports 23% increase in product sales
Finance - Device maker reports 7.5% decline in net revenues
Finance - Drug developer announces improved second quarter 2004 financial results
Finance - Drug discovery company announces second quarter 2004 financial results
Finance - Drug discovery company announces second quarter financial results
Finance - Drug discovery company raises $29 million in Series B financing
Finance - Drug re-engineering company announces $3M placement
Finance - Drug testing company announces financial results, dividend payout
Finance - Drugmaker provides Q2 update, reports net loss
Finance - Endocrine-focused biopharmaceutical company reports second quarter results
Finance - Gene therapy firm reports $32M Series B financing, provides pipeline update
Finance - Genomics company announces 2004 second quarter financial results
Finance - Genomics company reports productive quarter despite increased net losses
Finance - Given Imaging reports first profitable quarter
Finance - Guidance update provided by biotech firm
Finance - Healthcare products maker reports strong second quarter results
Finance - Healthcare services company announces results
Finance - Healthcare staffing, payroll service provider announces third quarter results
Finance - Healthcare-products provider announces $200M convertible senior note offering
Finance - Hemodialysis firm reports loss of $0.22 per share for second quarter
Finance - Hospice care provider announces improved financial results
Finance - Hospital services company announces second quarter earnings, continued growth
Finance - Immunotherapy company's second-quarter revenue dips
Finance - Information technology company announces strong second quarter
Finance - Information technology company reports second quarter 2004 results
Finance - Information technology vendor announces financial results
Finance - Information technology vendor reports 23% increase in first quarter revenues
Finance - Insurance company announces second quarter 2004 results
Finance - Insurance company reports second quarter 2004 results
Finance - Israeli company buys 463,000 shares of Given Imaging for approximately $16.2M
Finance - Israeli pharmaceutical company reports record sales and net income in Q2
Finance - LabChip maker reports 222% increase in revenues
Finance - MRI-focused pharma files registration statement for resale of 3.00% notes
Finance - Maker of COLD-EEZE reports second quarter results
Finance - Managed care company reports net loss for second quarter 2004
Finance - Medical Devices company reports fiscal 2004 year end results
Finance - Medical device maker reports second quarter results
Finance - Medical devices company reports improvements in third quarter 2004 results
Finance - Medical pressure-management products company increases annual dividend by 14%
Finance - Medical properties trust company reports second quarter 2004 results
Finance - Medical software company announces record revenue in second quarter
Finance - Microalgae company reports Q1 2005 net income of $113,000
Finance - Micropump maker reports Q2 revenues of $9.0 million, cash at $101 million
Finance - Monoclonal antibody technology company reports second quarter 2004 financial results
Finance - Nutritional supplements provider reports earnings
Finance - Offer for Aventis tender period expired
Finance - Oncology-focused biopharma reports record product revenues Q2 2004
Finance - Ophthalmic products producer reports second quarter results
Finance - Orajel maker reports increased net sales in second quarter
Finance - Patient-monitoring products company reports higher 2004 sales and net earnings
Finance - Pharma company announces second quarter 2004 financial results
Finance - Pharma company reports second quarter 2004 financial results
Finance - Pharmaceutical company announces 39% increase in second quarter total revenues
Finance - Pharmaceutical company announces initial public offering
Finance - Pharmaceutical company announces second quarter financial results
Finance - Pharmaceutical company reports 85% increase in second quarter revenue
Finance - Pharmaceutical company reports loss of $0.37 per share
Finance - Pharmaceutical company reports profitable first quarter
Finance - Pharmaceutical company reports second quarter financial, operating results
Finance - Pharmaceutical company reports second quarter results
Finance - Pharmaceutical firm announces stock repurchase program
Finance - Pharmaceutical firm extends exchange offer on 4.00% senior notes
Finance - Pharmaceutical firm raises $48M in Series C venture financing
Finance - Pharmaceutical firm reports 5% decrease in revenues
Finance - Pharmaceutical firm reports 53% increase in revenue due to Eligard sales
Finance - Pharmaceutical firm reports loss of $0.42 per share
Finance - Pharmaceutical firm reports quarterly loss of $0.12 per share
Finance - Pharmaceutical firm reports record sales of Hectorol
Finance - Pharmaceutical supplier reports 13% increase in sales
Finance - Pharmaceuticals company reports second quarter 2004 results
Finance - Pharmaceuticals company sells Czech Republic manufacturing operations
Finance - Plastic-film developer announces record operating results for Q3 2004
Finance - Provider of home infusion therapies announces financial results
Finance - Provider of newborn and maternal-fetal care announces financial results
Finance - Provider of ophthalmic digital imaging systems announces financial results
Finance - Senior living provider reports second quarter 2004 EPS results of $0.66
Finance - Small-molecule drug developer announces second quarter 2004 financial results
Finance - Specialty pharmaceuticals company reports second quarter 2004 results
Finance - Supplements maker revises statement about equity investment
Finance - Therapeutics company announces increase in second quarter revenue
Finance - Therapeutics manufacturer reports 89% revenue increase in second quarter
Finance - Third installment of $3 million dollars received for shares of biopolymer stock
Finance - U.K. companies urged to apply for EU R&D funding
Finance - Young pharmaceutical company completes round of equity financing
Finance - Zyflo Filmtab maker reports Q2 loss of $8.0 million
Fitness & Wellness - Federal study shows Washington, DC, has highest illicit drug use rate
Gastric Cancer - The novel cDNA DEGA may play a role in the etiology of gastric adenocarcinoma
Gene Activation - VEGF targeting of endothelial cells generates transient inflammation
Genetic Abnormalities - Ariol 2.0 launched as next-generation cellular imaging system
Genomics - Celera announces clinical milestone payment from Merck
Glaucoma - Approvable letter issued by FDA for Lumigan
HIV/AIDS - Sales of MedMira Rapid HIV Tests start in Canada
HIV/AIDS Gene Therapy - Lentivirus-based antisense vector inhibits HIV replication
HIV/AIDS Research - HIV-1-based vector used to develop mutants incapable of developing resistance
HIV/AIDS Therapy - Patient enrollment completed clinical trial of AVR118 in patients with AIDS
HIV/AIDS Treatment - FDA approves two fixed-dose combination drug products for HIV-1 infection
HIV/AIDS Treatment - U.S. FDA approves Truvada as part of HIV combination therapy
Health & Wellness - Nutrition technology company reports new study reports sports drink
Healthcare Coverage - Company reports Essure reimbursement grows to 149 million covered lives
Healthcare Coverage - Insurance company reports second quarter 2004 net income of $433 million
Heart Failure - Notified body for CE marketing of artificial heart in Europe appointed
Hemophilia - Pharmaceutical firm launches initiative to aid Kogenate FS patients
Hepatitis - Biotechnology company announces results of hepatitis C quality of life study
Hepatitis B Therapy - Multi-national phase II trial to study Remofovir in hepatitis B patients
High Cholesterol - Biopharmaceutical company to develop cholesterol absorption inhibitors
High Cholesterol - Cholesterol uproar fuels launch of new nutritional product
Hyperparathyroidism - Mimpara receives positive regulatory opinion for approval in Europe
Hypogonadism - Trial finds effective treatment for testosterone replacement
Imaging - College of Osteopathic Medicine enters agreement for portable ultrasound
Immunology - Central retinal vascular occlusion by orbital pseudotumor studied
Influenza - First influenza vaccine shipped to healthcare providers
Information Technology - Bioinformatics and laboratory solutions provider announces product licenses
Information Technology - EZ-CAP Product Suite add on evaluates performance of contracted physician groups
Information Technology - Firm releases 20M genotypes in new version of free SNP selection tool
Information Technology - Healthcare IT company signs RxPORTAL contracts with five existing customers
Information Technology - Healthcare reference platform launched
Information Technology - Information solutions provider and SIRC offer access to resources at the Olympics
Information Technology - Kentucky medical group selects practice management system
Information Technology - Life sciences company launches Computer System Validation Boot Camp
Information Technology - Operational monitoring and management solution announces partnership
Information Technology - Philips, TAGSYS and partner collaborate on supply chain management white paper
Information Technology - Scientists at Canada's Robarts Research Institute model functioning human organs
Information Technology - Software company supports AAFP Partners for Patients Program
Information Technology - Supply chain management prototype for healthcare unveiled
Legal Issues - Michigan's Medicaid program to receive $2.6M for prescription drug underpayment
Legal Issues - Pharma company negotiating settlement regarding Alapharma
Legal Issues - Pharmaceutical companies announce favorable court ruling on human growth hormone
Leukemia - Cell loading system used in phase I/II gene therapy trial for leukemia
Liquid Handling - PicoRAPTR workstation introduced for labs
Liver Fibrosis - Study demonstrates that FXR agonist can reverse liver fibrosis
Lymphoma - IL-6 levels and genotype are associated with risk of Hodgkin lymphoma
Malaria - Dose-ranging trial commences for malaria drug candidate DB289
Male Testosterone Deficiency - Top-line results announced from Opterone study for male testosterone deficiency
Malignant Glioma - IL13-PE38QQR study commences in malignant glioma patient at initial diagnosis
Market Analysis - Americans support HIV/AIDS prevention programs
Market Analysis - Forecasting company predicts anticholesterol market share for Vytorin
Medical Devices - Company begins human clinical trial in age related macular degeneration
Medical Devices - Diagnostic imaging company introduces cardiac CT imaging system at conference
Medical Devices - Electro-diagnostics for neuromuscular pain adopted by Georgia neurosurgeons
Medical Equipment - Mobile washing station for life sciences research introduced
Medical Equipment - New company to supply products, services to diabetic Medicare community, others
Medical Equipment - State University of New York reports on infrared imaging to detect breast cancer
Medical Equipment - U.S. FDA 510(k) clears new dose calculator for radiotherapy treatment plans
Melanoma Vaccine - Efficacy of melanoma vaccines enhanced in the absence of B lymphocytes
Mental Health - Researcher advises patients taking antidepressants not to stop abruptly
Mergers & Acquisitions - Business media company completes purchase of European, Asian healthcare media
Mergers & Acquisitions - Citigroup Venture Capital acquires medical-device company
Mergers & Acquisitions - Company acquires IP, manufacturing firm for injectable microsphere technology
Mergers & Acquisitions - Completion of contested merger, receipt of approvals confirmed by health group
Mergers & Acquisitions - Device firm's tender offer for notes expires
Mergers & Acquisitions - Drug development service provider acquires Toronto-based bioanalytical lab
Mergers & Acquisitions - Grant Ventures completes acquisition of diagnostics company
Mergers & Acquisitions - Healthcare services to the urology community to merge with HealthTronics
Mergers & Acquisitions - Pharmaceutical company board approves swap ratio for merger
Mergers & Acquisitions - Vision network acquired by financial holding company for $16 million cash
Migraine - Health plan introduces migraine management program
Multiple Myeloma - Over-expression of Bcl-X-L results in lymphoproliferative disease, malignancies
Multiple Sclerosis - Biotechnology holding company funds RPI-78M in Multiple Sclerosis assays study
Nanobacteria - Study demonstrates reversal of coronary artery calcification
Nanomedicine - Report: Nanomedicine brings fresh hope to the medical world
Neisseria - NadA diversity and carriage in Neisseria meningitidis reviewed
Non-Small Cell Lung Cancer - Genentech and partner announce NDA completion for Tarceva
Nutrition - Antioxidant supplements decrease risk of heart disease
Obesity - Pentagon, House and Senate committees urged to contact SUBWAY over ads
Obesity Prevention - Group encourages journalists to play role in struggle against obesity
Oncology - Tumor cells that secrete interleukin-13 have diminished tumorigenicity
Pain Management - Pharmaceutical company focused on pain management publishes research
Patents - Company issued U.S. patent covering method for treating stroke
Patents - Patent issued for diagnostic testing device
Patient Safety - Device firm modifies Super Luer Syringe Adapter to fight AIDS crisis
Patient Safety - Pharma society responds to patient safety agency findings for methotrexate
Pediatrics - ADHD medication equally affective in Caucasian, African American children
Peptic Ulcers - FDA clears POCone Infrared Spectrophotometer
Peripheral Arterial Disease - Coalition formed to educate public about peripheral arterial disease
Peripheral Vascular Disease - Enzyme inhibition aids collateral blood flow in ischemic animal models
Peripheral Vascular Disease - First patient treated in trial of LifeStent NT Self-Expanding Stent
Personnel - Aki Watanabe joins board of directors at biotech company
Personnel - Anesthesia services company appoints regional manager to drive expansion
Personnel - Aricept maker announces launch of new CNS sales force
Personnel - Arthur H. Rubenstein named to board of directors at diagnostics firm
Personnel - Biological products company names Robert J. Brown VP of corporate development
Personnel - Biopharmaceutical company announces new member of board of directors
Personnel - Biopharmaceutical company names vice president of business development
Personnel - Bruce Compton, PhD, named VP of chromatography operations
Personnel - Company specializing in single molecule DNA analysis appoints board members
Personnel - Dave Stack steps down from The Medicines Company; other management changes announced
Personnel - Dermatology organization appoints executive director
Personnel - Dr. Alexander Kavic appointed vice chairman of biotech company
Personnel - Former FDA executive to lead AustCancer development program
Personnel - Fred Halperin joins life sciences technology consulting firm
Personnel - Gerhard Mayr named special advisor to board of Maxygen sub
Personnel - Informatics company names Phillip M. Berman, MD, to board of directors
Personnel - Kevin J. Hart named president of insurance annuity distribution organization
Personnel - Life sciences firm appoints John R. Leone as president and CEO
Personnel - Meditech announces new chairman, new chief executive officer
Personnel - Michael Narachi elected board chair by sinusitis-focused drug company
Personnel - Nonprofit research supporter appoints vice president of business development
Personnel - Pain management company appoints scientific advisory board
Personnel - Payer market service provider announces executive VP of professional services
Personnel - Pharma company names senior vice president of sales and marketing
Personnel - Pharmaceutical company announces new chief scientific officer
Personnel - Pharmaceutical company names senior vice president, finance and administration
Personnel - Pharmaceutical firm appoints Joy Amundson as president, BioScience business
Personnel - RNAi company names Benjamin S. Levin general counsel
Personnel - Stem cell medical services company announces new VP, clinical development
Personnel - William Ringo leaves pharma's board to become CEO of Abgenix
Product Licensing - Nektar enters PEG technology agreement with Pfizer
Product Licensing - Purdue's exclusive option to license abuse-resistance technology has lapsed
Professional Training - Report helps R&D quality executives meet regulations and avoid fines
Prostate Cancer - Biopharmaceutical company provides update on DN-101 Plus Taxotere trial
Prostate Cancer - Proof-of-concept results of prostate cancer drug published in cancer journal
Psoriasis - Phase I trial results reported for Psoraxine
RNAi Research - Drosophila RNAi library released
Renal Cell Cancer - Maximal apoptosis of renal cell carcinoma is nuclear factor-kappa B dependent
Renal Cell Carcinoma - EMEA grants orphan drug designation to BAY 43-9006
Respiratory Therapy - Pediatric home health care company comments on proposed Medicare payments
Rhinovirus - Identification of the human rhinovirus serotype 1A binding site
Schizophrenia - Study links ACP-104 to improved cognition in schizophrenia patients
Security - DNA-based security firm joins alliance
Skin Infection - sNDA submitted for Merrem I.V. for complicated skin infections
Stem Cell Research - Christian Medical Assoc urges investment in stem cell research already in use
Stroke - German biotech firm to start phase II trials with its stroke therapy drug AX200
Supply Management - Covenant Health inks contract to manage supplies at point-of-use
Type 2 Diabetes - Canadian regulatory authority accepts Glumetza New Drug Submission for review
Vaccine Adjuvant - Microparticle adjuvant formulation for plasmid DNA vaccines characterized
Vaccine Development - Positive results announced from phase II trial of StreptAvax vaccine
Viral Vector - Herpes simplex virus vectors create transgene persistence in motor neurons
Women's Health - Health Secretary reminds mothers about the benefits of breastfeeding
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.